Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics.

Shinji Watanabe, Tokiko Watanabe, Takeshi Noda, Ayato Takada, Heinz Feldmann, Luke D Jasenosky, Yoshihiro Kawaoka
Author Information
  1. Shinji Watanabe: Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.

Abstract

We established a plasmid-based system for generating infectious Ebola virus-like particles (VLPs), which contain an Ebola virus-like minigenome consisting of a negative-sense copy of the green fluorescent protein gene. This system produced nearly 10(3) infectious particles per ml of supernatant, equivalent to the titer of Ebola virus generated by a reverse genetics system. Interestingly, infectious Ebola VLPs were generated, even without expression of VP24. Transmission and scanning electron microscopic analyses showed that the morphology of the Ebola VLPs was indistinguishable from that of authentic Ebola virus. Thus, this system allows us to study Ebola virus entry, replication, and assembly without biosafety level 4 containment. Furthermore, it may be useful in vaccine production against this highly pathogenic agent.

References

  1. Virology. 2001 Apr 25;283(1):1-6 [PMID: 11312656]
  2. J Virol. 2001 Jun;75(11):5205-14 [PMID: 11333902]
  3. Virology. 2001 Aug 1;286(2):384-90 [PMID: 11485406]
  4. J Virol. 2001 Dec;75(23):11677-85 [PMID: 11689649]
  5. J Virol. 2002 Jan;76(1):406-10 [PMID: 11739705]
  6. J Virol. 1999 Mar;73(3):2333-42 [PMID: 9971816]
  7. J Virol. 1999 Oct;73(10):8907-12 [PMID: 10482652]
  8. J Virol. 2000 May;74(10):4933-7 [PMID: 10775638]
  9. J Mol Biol. 2000 Jun 30;300(1):103-12 [PMID: 10864502]
  10. Nat Med. 2000 Aug;6(8):886-9 [PMID: 10932225]
  11. EMBO J. 2000 Aug 15;19(16):4228-36 [PMID: 10944105]
  12. J Gen Virol. 2000 Sep;81(Pt 9):2155-9 [PMID: 10950971]
  13. J Virol. 2000 Nov;74(21):10194-201 [PMID: 11024148]
  14. Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13871-6 [PMID: 11095724]
  15. Virology. 2000 Dec 5;278(1):20-6 [PMID: 11112476]
  16. EMBO J. 2000 Dec 15;19(24):6732-41 [PMID: 11118208]
  17. J Virol. 2001 Mar;75(6):2660-4 [PMID: 11222689]
  18. Science. 2001 Mar 9;291(5510):1965-9 [PMID: 11239157]
  19. J Virol. 2002 Jan;76(2):767-73 [PMID: 11752166]
  20. J Virol. 2002 Mar;76(5):2518-28 [PMID: 11836430]
  21. J Virol. 2002 May;76(10):4855-65 [PMID: 11967302]
  22. Mol Cell. 2002 Aug;10(2):307-16 [PMID: 12191476]
  23. J Virol. 2003 Jan;77(2):1069-74 [PMID: 12502822]
  24. J Virol. 2003 Feb;77(3):1793-800 [PMID: 12525613]
  25. Adv Virus Res. 1996;47:1-52 [PMID: 8895830]
  26. Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14764-9 [PMID: 9405687]
  27. Virology. 1998 Jun 20;246(1):134-44 [PMID: 9657001]
  28. J Virol. 1998 Aug;72(8):6442-7 [PMID: 9658086]
  29. Mol Cell. 1998 Nov;2(5):605-16 [PMID: 9844633]

MeSH Term

Animals
COS Cells
Cell Line
Chlorocebus aethiops
DNA, Complementary
Ebolavirus
Green Fluorescent Proteins
Humans
Luminescent Proteins
Microscopy, Electron
Microscopy, Electron, Scanning
Plasmids
RNA, Viral
Vero Cells
Viral Envelope Proteins
Virion
Virology

Chemicals

DNA, Complementary
Luminescent Proteins
RNA, Viral
Viral Envelope Proteins
Green Fluorescent Proteins

Word Cloud

Created with Highcharts 10.0.0Ebolasystemvirusinfectiousvirus-likeparticlesVLPsgeneratedreversegeneticswithoutebolaestablishedplasmid-basedgeneratingcontainminigenomeconsistingnegative-sensecopygreenfluorescentproteingeneproducednearly103permlsupernatantequivalenttiterInterestinglyevenexpressionVP24TransmissionscanningelectronmicroscopicanalysesshowedmorphologyindistinguishableauthenticThusallowsusstudyentryreplicationassemblybiosafetylevel4containmentFurthermoremayusefulvaccineproductionhighlypathogenicagentProductionnovelcDNAs:alternativegeneration

Similar Articles

Cited By (76)